Search

Search Constraints

You searched for: Author/Creator Salim, Bob

Search Results

2. Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma. Issue 4 (20th April 2021)